Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Eur J Pharm Biopharm. 2021 Mar 24;163:72–101. doi: 10.1016/j.ejpb.2021.03.010

Table 7.

Advantages and disadvantages of commonly used biomaterials for cancer immunotherapy.

Biomaterials Advantage Disadvantage
Zinc Easily functionalized, capability for multimodal imaging, optical and piezoelectric properties, antibacterial and antifungal nature. Low stability, non-uniform size distribution, requirement of advanced equipment, risk of cytotoxicity and genotoxicity, skin and environment hazard
PLGA High reproducibility and purity over natural polymer, no requirement of highly toxic solvents. High size variability with change in concentration, low drug entrapment efficiency, high-cost, lack of surface functionalization
PLHMGA Tailorable release rate, better compatibility with protein, not susceptible to acids during degradation Difficult to prepare
Chitosan High biocompatibility and biodegradability, wound healing and antimicrobial properties. Low solubility in physiological pH, low porosity, stability & mechanical resistance.